Genentech, Inc.
Clinical trials sponsored by Genentech, Inc., explained in plain language.
-
New hope for breast cancer patients who Can't handle standard hormone pills
Disease control Not yet recruitingThis study tests a drug called giredestrant in 300 women with early-stage, hormone-sensitive breast cancer who had to stop their previous hormone therapy due to side effects like joint pain or hot flashes. The goal is to see if patients stick with this new treatment and how it af…
Phase: PHASE3 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New hope for myeloma patients Who've run out of options?
Disease control Not yet recruitingThis study tests a new drug called RO7851624 in about 160 people with multiple myeloma that has come back or stopped responding to standard treatments. The main goal is to check the drug's safety and how the body processes it. Participants must have tried several prior therapies …
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated May 19, 2026 12:00 UTC